GE HealthCare has dosed the first patient in its Phase II/III LUMINA clinical trial for the investigational manganese-based MRI contrast agent, mangaciclanol.

The agencies’ initiative is intended to speed up the processes involved in medical devices’ securing Medicare coverage once approved by the FDA.

Imricor will present the NorthStar mapping system at the Heart Rhythm Society’s Annual Scientific Sessions in Chicago. Credit: Imricor. Imricor Medical Systems has started commercial distribution of ...

Edwards Lifesciences revealed that its Q1 2026 performance was better than expected, prompting it to uplift its previous FY26 outlook.

Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.

AcuityMD plans to use AI to further advance its foundational platform designed for streamlining commercial execution protocols for medtech companies.

OEMs continue to prioritise high-growth segments of the medtech industry such as pulsed-field ablation (PFA), while conflict in the Middle East is impacting IPO activity.

Medtronic has completed the acquisition of CathWorks, a company specialising in advancing the diagnosis and treatment of CAD, for $585m.

Pulnovo Medical has completed an oversubscribed $100m strategic financing round, with Medtronic as the lead investor.

The funds from Trinity Capital are expected to advance commercialisation efforts for Cala Health’s device for alleviating tremors in Parkinson’s and essential tremor patients.

BVI’s next-generation cataract and vitreoretinal procedure platform has been developed with features that are intended at improving patient outcomes.

ScreenPoint’s Transpara AI is integrated with Siemens Healthineers tools, including syngo.Breast Care and its MAMMOMAT range.